Suspicions Raised Over Medytox’s Botulinum Toxin Amid Ongoing Court Battle
Executive Summary
Shares of Korea's Medytox fell on suspicions that it supplied botulinum toxin to local hospitals before the product's approval in 2006. The concerns add to other manufacturing issues that have been denied by the company, which pointed to a rival as the possible source amid an ongoing legal battle over the strain used in the product.